Select a Meeting...
- SHM Converge 2023
- SHM Converge 2022
- SHM Converge 2021
- Hospital Medicine 2020, Virtual Competition
- Hospital Medicine 2019, March 24-27, National Harbor, Md.
- Hospital Medicine 2018; April 8-11; Orlando, Fla.
- Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
- Hospital Medicine 2016, March 6-9, San Diego, Calif.
- Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
- Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
- Hospital Medicine 2013, May 16-19, National Harbor, Md.
- Hospital Medicine 2012, April 1-4, San Diego, Calif.
- Hospital Medicine 2011, May 10-13, Dallas, Texas.
- Hospital Medicine 2010, April 8-11, Washington, D.C.
- Hospital Medicine 2009, May 14-17, Chicago, Ill.
- Hospital Medicine 2008, April 3-5, San Diego, Calif.
- Hospital Medicine 2007, May 23-25, Dallas, Texas
- Hospital Medicine 2006, May 3-5, Washington, D.C.
Meetings Archive For Hospital Medicine 2011, May 10-13, Dallas, Texas...
Abstract Number: 1
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: The Centers for Disease Control and Prevention recommended in 2006 to test all patients for HIV without requiring counseling or written consent. The CDC suggested “opt‐out” testing to increase adoption. In 2007, California removed the legal requirement for written consent. However, the volume of HIV tests in the University of California, San Francisco infectious […]
Abstract Number: 2
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Patients often need arthrocentesis for diagnostic and therapeutic reasons while on chronic warfarin therapy. Often the procedure is delayed or avoided because of concern about bleeding. The aim of this retrospective study was to determine the safety of arthrocentesis in patients on chronic oral warfarin therapy with INR ≥ 2.0. Methods: We reviewed the […]
Abstract Number: 3
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Venous thromboembolism (VTE) is a source of morbidity and mortality for high‐risk populations. The risk of VTE in homebound patients is unknown, and therefore it is unclear whether they should be offered VTE prophylaxis when feasible. The purpose of this retrospective cohort study was to estimate the incidence of venous thromboem‐bolism (VTE) in homebound […]
Abstract Number: 4
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Bone marrow examination is useful in the diagnosis and staging of hematologic disease, as well as in the assessment of overall bone marrow cellularity. The procedure can be a difficult experience for the patient. Pain and anxiety may play a role in the experience. The purpose of the study was to assess practices for […]
Abstract Number: 5
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Low‐molecular‐weight heparins are the most commonly used for thromboembolic disease prophylaxis, probably because of their security profile and once‐daily administration. Contrary to therapeutic doses, prophylactic recommended doses are fixed (40 mg once a day for enoxaparin). Dosing in extreme body weights has little evidence, especially in patients with low weight. The aim of the study […]
Abstract Number: 6
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: The cohesiveness of the discharge process is critical for ensuring the safety and quality of transition of patient care from the inpatient setting to the next level of care. The discharge process is often viewed as chaotic by the health care team as well as patients and families. A few reasons why the discharge […]
Abstract Number: 7
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Hospital care accounts for more than 30% of health care expenditures in the United States. In an effort to reduce inappropriate admissions, we implemented hospital medicine attending screening of non–intensive care unit (ICU) medicine admissions. Methods: We conducted a before and after study at our urban, academic safety‐net hospital. From January to June 2008, […]
Abstract Number: 8
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Observational studies have reported significant protective associations between 25‐hydroxyvitamin D [25(OH) D] and all‐cause and cardiovascular (CV) mortality. We believe that these associations have nonlinear relationships and 25(OH) D probably offers greater protection at lower serum levels. To study this hypothesis, we examined the relationship between 25(OH) D and all‐cause and CV mortality in […]
Abstract Number: 9
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Patients hospitalized for medical illness are at an increased risk of developing venous thromboembolism (VTE). The present study retrospectively assessed the incidence and time course of symptomatic VTE events following hospitalization in a large, real‐world patient population. Methods: Administrative claims data derived from the Thomson Reuters MarketScan® Inpatient Drug Link File were used to […]
Abstract Number: 10
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Background: Hyponatremia (HN) is the leading electrolyte abnormality among hospitalized patients. In the absence of symptoms, HN is often overlooked as a condition that warrants aggressive intervention. However, a careful history often reveals symptoms associated with HN. Although HN is common, little is known regarding the influence of HN on patient outcomes and health care […]